Continued donepezil treatment is effective for Alzheimer's disease

03/8/2012 | PhysiciansBriefing.com

A U.K. study involving 295 patients with moderate to severe Alzheimer's disease found that those who continued taking donepezil experienced significant cognitive and functional benefits compared with patients who stopped taking donepezil after three months. The findings appeared in The New England Journal of Medicine.

View Full Article in:

PhysiciansBriefing.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN